Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07YHN
|
|||
Drug Name |
AC1LFGWU
|
|||
Synonyms |
AC1LFGWU; Oprea1_144688; SCHEMBL16409995; ZINC310666; STK508156; AKOS003273711; MCULE-1481833521; ST45014551; SR-01000248344; SR-01000248344-1; 8-(4-methyl(1,2,4-triazol-3-ylthio))-5-nitroquinoline; 8-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-5-nitroquinoline; 8-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]-5-nitroquinoline
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H9N5O2S
|
|||
Canonical SMILES |
CN1C=NN=C1SC2=C3C(=C(C=C2)[N+](=O)[O-])C=CC=N3
|
|||
InChI |
1S/C12H9N5O2S/c1-16-7-14-15-12(16)20-10-5-4-9(17(18)19)8-3-2-6-13-11(8)10/h2-7H,1H3
|
|||
InChIKey |
RMYCZXRLBFQOFF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 345991-02-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | NAD-dependent deacetylase sirtuin-2 (SIRT2) | Target Info | Inhibitor | [1] |
Target's Patent Info | NAD-dependent deacetylase sirtuin-2 (SIRT2) | Target's Patent Info | [1] | |
Pathway Interaction Database | Signaling events mediated by HDAC Class III | |||
Signaling events mediated by HDAC Class I |
References | Top | |||
---|---|---|---|---|
REF 1 | Small molecule activators of NRF2 pathway. US9737525. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.